As for patients with NHL, chemotherapy-based mobilization using ICE plus G-CSF showed superior mobilization efficacy and comparable toxicity profile than plerixafor-based mobilization in a retrospective study, the efficacy and safety of other chemotherapy regimens versus plerixafor required to be investigated with further research [82]. This evidence concerns the gene CSF3 and non-Hodgkin lymphoma.